Incannex announces positive results from phase 2 clinical trial investigating the effect of IHL-42X for treatment of obstructive sleep apnoea ...Middle East

Highlights: IHL-42X reduced primary endpoint apnoea hypopnea index relative to baseline at all three doses that were assessed Low dose IHL-42X exhibited superior safety and efficacy metrics to mid and high doses Low dose IHL-42X reduced AHI by an average of 50.7% compared to baseline with...

Hence then, the article about incannex announces positive results from phase 2 clinical trial investigating the effect of ihl 42x for treatment of obstructive sleep apnoea was published today ( Friday 03/06/2022 - 03:04 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Incannex announces positive results from phase 2 clinical trial investigating the effect of IHL-42X for treatment of obstructive sleep apnoea )

Also on site :

• I-70 closed in Glenwood Canyon for safety concerns, police activity
• Russian cat becomes world champion 2025
• Kiev awards major mining project to Trump-linked investors